Sensitizing composition using electromagnetic waves for thermal therapy of cancers, and cancer therapy using same
Disclosed are a sensitizing composition for thermal cancer therapy using electromagnetic waves and a method of treating cancer using the composition. The sensitizing composition includes a metal ion, a metal ion-bound material, metal ion-noncovalently bound apotransferrin (transferrin), or a metal ion-noncovalently bound apotransferrin derivative. The sensitizing composition enables selective delivery of the metal ion to tumorous tissue when administered in vivo, and thus the generation of heat in tumorous tissue in which the metal ion accumulates is increased upon thermal cancer therapy using electromagnetic waves, thereby maximizing efficacy of thermal cancer therapy using electromagnetic waves in treating cancer. Thermal therapy using the sensitizing composition effectively treats cancer without pain or side effects and is thus expected to be widely useful in anticancer treatment as monotherapy, and/or in combination with chemotherapy, radiation therapy, or a combination thereof, ultimately increases the potential to cure cancer.
1. A method of treating an animal subject with cancer, consisting of:
(a) administering a composition to the animal subject,
wherein the composition consists of
(i) a sensitizer which is a metal ion-carbohydrate complex in which (i-a) a metal ion selected from the group consisting of an iron ion and a magnesium ion is noncovalently bound to (i-b) a carbohydrate selected from the group consisting of carboxymaltose, isomaltoside, and starch; and
(ii) water as a pharmaceutically acceptable carrier, and
wherein the administering the composition results in localization of the metal ion of the metal-carbonhydrate complex in a cancerous tissue of the animal; and
(b) applying electromagnetic waves to the animal subject thereby generating amplified heat at cancerous tissue compared to non-cancerous tissues,
wherein the applying electromagnetic waves causes a decrease in a size of cancerous mass of the cancerous tissue.
2. The method according to claim 1 , wherein the sensitizer is administered in a dose of 0.1 to 50 mg/kg.
3. The method according to claim 1 , wherein the electromagnetic waves are selected from the group consisting of gamma rays, X-rays, UV rays, visible light, IR light, microwaves, and radio waves.
4. The method according to claim 1 , wherein the method is performed in combination with one or more therapy selected from the group consisting of chemotherapy, radiation therapy, biological therapy, immunotherapy, and photodynamic therapy.